Edition:
United States

Spectranetics Corp (SPNC.OQ)

SPNC.OQ on NASDAQ Stock Exchange Global Select Market

25.05USD
3:59pm EST
Change (% chg)

$-0.15 (-0.60%)
Prev Close
$25.20
Open
$25.20
Day's High
$25.40
Day's Low
$24.95
Volume
54,159
Avg. Vol
100,705
52-wk High
$26.15
52-wk Low
$11.09

SPNC.OQ

Chart for SPNC.OQ

About

The Spectranetics Corporation is a United States-based company, which develops, manufactures, markets and distributes medical devices used in minimally invasive procedures within the cardiovascular system. The Company’s products are available in over 65 countries and are used to cross, prepare and treat arterial blockages in the... (more)

Overall

Beta: 1.63
Market Cap(Mil.): $1,088.72
Shares Outstanding(Mil.): 43.20
Dividend: --
Yield (%): --

Financials

  SPNC.OQ Industry Sector
P/E (TTM): -- 59.99 30.38
EPS (TTM): -1.31 -- --
ROI: -15.19 7.20 14.86
ROE: -53.53 10.77 16.28

BRIEF-Spectranetics receives CE mark for Stellarex 0.014 drug-coated balloon

* Spectranetics receives CE mark for stellarex 0.014" drug-coated balloon Source text for Eikon: Further company coverage:

Nov 21 2016

BRIEF-Spectranetics posts positive trial results for stellarex drug-coated balloon illumenate

* Spectranetics Corp announces final 12-month results of stellarex drug-coated balloon (DCB) illumenate pivotal trial

Nov 02 2016

BRIEF-Spectranetics files for FDA approval of Stellarex drug-coated balloon

* Spectranetics corp - preparing for our launch into united states market, which we anticipate in second half of 2017

Nov 02 2016

BRIEF-Spectranetics Q3 loss per share $0.31

* Spectranetics reports third quarter 2016 revenue of $68.3 million

Oct 27 2016

BRIEF-Spectranetics Q2 loss per share $0.35

* FY2016 earnings per share view $-1.11, revenue view $262.7 million -- Thomson Reuters I/B/E/S

Jul 28 2016

Earnings vs. Estimates